Used in peptide synthesis as a chiral building block for the preparation of bioactive molecules, particularly in the development of enzyme inhibitors and receptor ligands. The quinoline moiety enables interactions with aromatic and hydrophobic binding sites in proteins, making it valuable in medicinal chemistry for designing compounds with enhanced target affinity and selectivity. Commonly employed in solid-phase peptide synthesis (SPPS) due to the Fmoc protecting group, allowing mild deprotection conditions compatible with sensitive sequences. Also utilized in research for creating fluorescent probes, as the fluorenyl group contributes to UV detectability and can aid in purification and tracking during synthesis.